The independent source for health policy research, polling, and news.
Showing 81 - 100 of 582
A new poll reveals enthusiasm for a pricey new generation of weight loss drugs, but interest drops if users potentially have to deal with weekly injections, lack of insurance coverage, or a need to continue the medications indefinitely to avoid regaining weight.
House Republican legislation promises more health insurance options but fewer protections, even as the Biden administration seeks to rein in short-term plans, which were expanded in the Trump era.
The “front door” to the health system is changing, under pressure from increased demand, consolidation, and changing patient expectations.
The billion-dollar amount cited by former Sen. Al Franken, while an estimate, is likely very close to what insurers will owe this year under a provision of the Affordable Care Act that compels rebates when insurers spend too little on actual medical care.
A federal judge’s recent ruling on the Affordable Care Act is by no means the final word. Even parsing its impact is complicated. Here are key issues to watch as the case works its way through the legal system.
Despite record enrollment in health insurance plans under the Affordable Care Act, some consumers who bought coverage and agents who helped them do so have had a tough start to the new year: Many say it’s hard to find an in-network doctor or hospital.
A U.S. District Court ruling overturned the section of the Affordable Care Act that makes preventive health services — from colonoscopies to diabetes screenings and more — available at no cost to consumers.
Insurers, employers, and taxpayers will all be affected as drug manufacturers move these products to the commercial market.
KHN has teamed up with our partners at PolitiFact to monitor 100 key promises made by Joe Biden during the 2020 presidential campaign — including those surrounding the Affordable Care Act.
Another effort to make upfront cost comparisons possible in an industry known for its opaqueness: an online tool for consumers to get some idea of what they may pay for medical care.
Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.
Consumers may find relief in some key changes made by Congress and the Biden administration, although other issues remain unsettled.
People now have at their disposal more medicines that are effective at reducing weight, but none can counter obesity alone. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.
Smoke- and ash-filled air can trigger or exacerbate severe respiratory conditions. But the medical specialists who treat these illnesses are often scarce where they are most in need.
The human body mass index — a simple mathematical equation — is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.
A federal judge in Texas issued a decision this week that affects the Affordable Care Act. It says one way that preventive services are selected for no-cost coverage is unconstitutional.
A TV and social media ad offers a reason to check on the enforcement of a sweeping rule that requires hospitals to post information about what they charge insurers and cash-paying patients.
Health insurers and self-insured employer plans are now required to post their negotiated rates for almost every type of medical service. But navigating through the trove of information is no easy task.
Even before the Supreme Court struck down the constitutional right to abortion, insurance coverage for the service varied widely. Now it’s become even more complex, with additional changes and court challenges to come.
Even a decade in, the Affordable Care Act’s recommendations to simply cover preventive screening and care without cost sharing remain confusing and complex.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF